| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |